Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update describes evaluating the safety and preliminary efficacy of a triplet regimen (glofitamab, gemcitabine, and oxaliplatin) in U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Glofitamab (Columvi) (glofitamab)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphoma | Phase 1 | Status: RECRUITING